Article

The Metabolic Syndrome and Cardiovascular Risk: A Systematic Review and Meta-Analysis

Jewish General Hospital/McGill University, Montreal, Quebec, Canada.
Journal of the American College of Cardiology (Impact Factor: 15.34). 09/2010; 56(14):1113-32. DOI: 10.1016/j.jacc.2010.05.034
Source: PubMed

ABSTRACT We sought to conduct a systematic review and meta-analysis of the cardiovascular risk associated with the metabolic syndrome as defined by the 2001 National Cholesterol Education Program (NCEP) and 2004 revised National Cholesterol Education Program (rNCEP) definitions.
Numerous studies have investigated the cardiovascular risk associated with the NCEP and rNCEP definitions of the metabolic syndrome. There is debate regarding the prognostic significance of the metabolic syndrome for cardiovascular outcomes.
We searched the Cochrane Library, EMBASE, and Medline databases through June 2009 for prospective observational studies investigating the cardiovascular effects of the metabolic syndrome. Two reviewers extracted data, which were aggregated using random-effects models.
We identified 87 studies, which included 951,083 patients (NCEP: 63 studies, 497,651 patients; rNCEP: 33 studies, 453,432 patients). There was little variation between the cardiovascular risk associated with NCEP and rNCEP definitions. When both definitions were pooled, the metabolic syndrome was associated with an increased risk of cardiovascular disease (CVD) (relative risk [RR]: 2.35; 95% confidence interval [CI]: 2.02 to 2.73), CVD mortality (RR: 2.40; 95% CI: 1.87 to 3.08), all-cause mortality (RR: 1.58; 95% CI: 1.39 to 1.78), myocardial infarction (RR: 1.99; 95% CI: 1.61 to 2.46), and stroke (RR: 2.27; 95% CI: 1.80 to 2.85). Patients with the metabolic syndrome, but without diabetes, maintained a high cardiovascular risk.
The metabolic syndrome is associated with a 2-fold increase in cardiovascular outcomes and a 1.5-fold increase in all-cause mortality. Studies are needed to investigate whether or not the prognostic significance of the metabolic syndrome exceeds the risk associated with the sum of its individual components. Furthermore, studies are needed to elucidate the mechanisms by which the metabolic syndrome increases cardiovascular risk.

Download full-text

Full-text

Available from: Salvatore Mottillo, Oct 07, 2014
1 Follower
 · 
198 Views
  • Source
    • "of MS is increased in obesity [11] and is associated with atherothrombotic complications in micro-and macrovascular territories [12] [13]. The syndrome is also strongly associated with the increased risk of coronary heart disease and type 2 diabetes mellitus (T2DM) [14] [15] [16] [17]. The abnormal metabolic state that accompanies diabetes causes arterial dysfunction. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. The aim of this study was to examine the prevalence of metabolic syndrome (MS) components in an urban Mexican sample. Methods. A total of 854 subjects were included. Anthropometric, blood pressure measurements, clinical data, and overnight fasting blood samples were obtained from all subjects. Results. In accordance with definitions by the American Heart Association/ National Heart, Lung, and Blood Institute (AHA/NHLBI) and the International Diabetes Federation (IDF), the prevalence of MS among participants was 59.7 and 68.7%, respectively. The prevalence of MS was higher in women and in individuals older than 45 years of age. More than 40% of the subjects fulfilled four criterions of MS according to both definitions. Conclusions. There was a high prevalence of MS components in an urban Mexican sample. Therefore, strong strategies had to be developed for early detection of MS and its components to prevent DMT2 and atherothrombotic complications in these patients.
    Experimental Diabetes Research 01/2012; 2012:202540. DOI:10.1155/2012/202540 · 3.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Coronary heart disease is the leading killer of women worldwide. Empirical literature documents substantial morbidity and mortality benefits for cardiac rehabilitation participants. Scientific advances have informed the development of evidence-based guidelines for improving the delivery of cardiac rehabilitation yet persistent themes surrounding the substandard referral and utilization rates by women continue unabated in the literature. This review provides an update of the current status of cardiac rehabilitation for women, including a brief overview of the latest findings regarding the unique presentations of heart disease in women. An innovative secondary prevention program, designed exclusively for women is described, and illustrates an attempt to modify a contemporary traditional cardiac rehabilitation program to improve attendance rates and health outcomes in women. Future research with large, diverse samples of women are essential for guiding gender-appropriate referral strategies, effective modifications to traditional center-based programs, and the efficacy of alternative cardiac rehabilitation care models for women.
    Current Cardiovascular Risk Reports 10/2012; 6(5). DOI:10.1007/s12170-012-0255-z
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Lipid accumulation product (LAP) has been advocated as a simple clinical indicator of metabolic syndrome (MS). However, no studies have evaluated the accuracy of LAP in predicting MS in Taiwanese adults. The aim of our investigation was to use LAP to predict MS in Taiwanese adults. Methods Taiwanese adults aged 50 years and over (n = 513) were recruited from a physical examination center at a regional hospital in southern Taiwan. MS was defined according to the MS criteria for Taiwanese people. LAP was calculated as (waist circumference [cm] − 65) × (triglyceride concentration [mM]) for men, and (waist circumference [cm] − 58) × (triglyceride concentration [mM]) for women. Simple logistic regression and receiver-operating characteristic (ROC) analyses were conducted. Results The prevalence of MS was 19.5 and 21.5% for males and females, respectively. LAP showed the highest prediction accuracy among adiposity measures with an area under the ROC curve (AUC) of 0.901. This was significantly higher than the adiposity measure of waist-to-height ratio (AUC = 0.813). Conclusions LAP was a simple and accurate predictor of MS in Taiwanese people aged 50 years and over. LAP had significantly higher predictability than other adiposity measures tested.
    BMC Cardiovascular Disorders 09/2012; 12(1). DOI:10.1186/1471-2261-12-78 · 1.50 Impact Factor
Show more